|
05 March, 2012
|
ICON Selected by Roche for Technology Partnership
|
|
|
28 February, 2012
|
ICON Acquires PriceSpective
|
|
|
16 February, 2012
|
ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
15 February, 2012
|
ICON Completes Acquisition of BeijingWits Medical Consulting Ltd
|
|
|
09 January, 2012
|
ICON Selected by Shire plc's Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services
|
|
|
27 December, 2011
|
ICON Announces Dr. Anthony Murphy To Retire From Board of Directors
|
|
|
12 December, 2011
|
ICON Acquires BeijingWits Medical Consulting Ltd
|
|
|
22 November, 2011
|
ICON plc: Commencement of Share Repurchase Programme
|
|
|
01 November, 2011
|
ICON Names New Global Head of Clinical Research Services
|
|
|
27 October, 2011
|
ICON Reports Q3 revenue growth of 7% to $241 million and net new business of $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
07 September, 2011
|
ICON Announces Peter Gray To Retire As CEO
|
|
|
30 August, 2011
|
ICON Selected as a Preferred Provider for Early Phase Clinical Development by Bristol-Myers Squibb
|
|
|
20 July, 2011
|
ICON Reports Second Quarter 2011 Net New Business of $310 million, Revenue of $233 million and EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
19 July, 2011
|
ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
|
|
|
14 July, 2011
|
ICON Acquires Firecrest Clinical
|
|
|
26 May, 2011
|
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
|
|
|
11 May, 2011
|
ICON Forms Strategic Alliance With Boston Clinical Research Institute
|
|
|
04 May, 2011
|
Investigative Sites Worldwide Rate ICON as a Top CRO According to Industry Survey
|
|
|
21 April, 2011
|
ICON Reports First Quarter 2011 Revenue up 5% to $229 Million and EPS of 21c
|
|
|
20 April, 2011
|
ICON and ACRONET Sign Alliance Agreement in Japan
|
|
